TBC India National Institute for Research in Tuberculosis International Union against Tuberculosis and Lung Disease Project Axshya Partnership for Tuberculosis Care and Control in India Stop TB Partnership The Lilly MDR-TB Partnership Centers for Disease Control and Prevention World Health Organization (WHO) India Tuberculosis The Indian Journal of Tuberculosis
This is the official website for the Revised National Tuberculosis Control Programme in India and an excellent resource for recent data and information on TB in the country.
The National Institute for Research in Tuberculosis (formerly known as Tuberculosis Research Centre) is an internationally recognised TB research centre. It is a Supranational Reference Laboratory and collaborates with the WHO for training and research.
The Union strives to find innovative solutions and give expertise and support to address health challenges in middle and low income countries. Headquartered in Paris, it has around 10,000 members across 145 countries. REACH works closely with the Union South-East Asia Office, based in New Delhi.
Project Axshya is a Global Fund Round 9 civil society initiative to support and strengthen TB care and control in India. Launched in 2010, it focuses on advocacy, communication and social mobilisation activities through a national network of partner organisations (including REACH) who will implement them in their respective states and districts through their own sub-networks.
The Partnership brings together organisations across the country on a common platform and seeks to harness the strengths and expertise of partners in various technical and implementation areas, and to empower affected communities, in TB care and control.
The Stop TB Partnership is a collective international force that leads the fight against TB in more than a 100 countries. It seeks to accelerate access to TB diagnosis and treatment as well as research and development.
The Partnership is a public-private initiative by Eli Lilly and Company along with civil society, academic institutions and private enterprises to address the multi-drug resistance tuberculosis (MDR-TB) crisis.
CDC is a US Federal Agency concerned with public health and safety through partnerships with state health departments and other organisations. It is based in Atlanta, Georgia.
WHO India strategises and implements the Revised National Tuberculosis Control Programme (RNTCP) along with the Government of India.
Tuberculosis is a specialty journal that publishes original biomedical research on TB, particularly on bacteriological, immunological and pathogenesis aspects of the disease.
The Indian Journal of Tuberculosis publishes academic research on TB from India.
National Institute for Research in Tuberculosis
International Union against Tuberculosis and Lung Disease
Partnership for Tuberculosis Care and Control in India
Stop TB Partnership
The Lilly MDR-TB Partnership
Centers for Disease Control and Prevention
World Health Organization (WHO) India
The Indian Journal of Tuberculosis